Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thyroid cancer, medullary × sacubitril and valsartan sodium hydrate drug combination × 1 year × Clear all

Sponsor

Conditions

Neoplasms 1 Lymphoma, Follicular 1 Hypertension 1 Heart Failure 1

Interventions

3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡